Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-26-001013·ArriVent BioPharma, Inc.
Schedule 13G ownership disclosure
ArriVent Biopharma Inc
Common Stock, par value $0.0001 per share · CUSIP: 04272N102
Event date: 2025-12-31
- Filing-level shares
- 3,929,117.00
- Percent of class
- 9.5%
- Hillhouse Investment Management, Ltd.
Shares: 3,929,117.00 · Class: 9.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-001013
- Form type
- SCHEDULE 13G/A
- Filer
- ArriVent BioPharma, Inc.
- CIK
- CIK 1868279
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership